Sun G, Zhao C, Han J, Wu S, Chen Y, Yao J
Cell Oncol (Dordr). 2024; 47(6):2073-2090.
PMID: 39543064
DOI: 10.1007/s13402-024-01011-y.
Herdiansyah M, Rizaldy R, Alifiansyah M, Fetty A, Anggraini D, Agustina N
Narra J. 2024; 4(2):e775.
PMID: 39280296
PMC: 11391962.
DOI: 10.52225/narra.v4i2.775.
Conger K, Chidley C, Ozgurses M, Zhao H, Kim Y, Semina S
Cell Rep. 2024; 43(8):114552.
PMID: 39068660
PMC: 11406281.
DOI: 10.1016/j.celrep.2024.114552.
Min C, Nwachukwu J, Hou Y, Russo R, Papa A, Min J
Proc Natl Acad Sci U S A. 2024; 121(24):e2321344121.
PMID: 38830107
PMC: 11181081.
DOI: 10.1073/pnas.2321344121.
Evangelidis P, Evangelidis N, Kalmoukos P, Kourti M, Tragiannidis A, Gavriilaki E
Curr Issues Mol Biol. 2024; 46(5):4787-4802.
PMID: 38785556
PMC: 11119915.
DOI: 10.3390/cimb46050288.
Infliximab, a Monoclonal Antibody against TNF-α, Inhibits NF-κB Activation, Autotaxin Expression and Breast Cancer Metastasis to Lungs.
Shinde A, Tang X, Singh R, Brindley D
Cancers (Basel). 2024; 16(1).
PMID: 38201482
PMC: 10778319.
DOI: 10.3390/cancers16010052.
ASCT2 is the primary serine transporter in cancer cells.
Conger K, Chidley C, Ozgurses M, Zhao H, Kim Y, Semina S
bioRxiv. 2023; .
PMID: 37873453
PMC: 10592681.
DOI: 10.1101/2023.10.09.561530.
Meta-analysis of integrated ChIP-seq and transcriptome data revealed genomic regions affected by estrogen receptor alpha in breast cancer.
Piryaei Z, Salehi Z, Ebrahimie E, Ebrahimi M, Kavousi K
BMC Med Genomics. 2023; 16(1):219.
PMID: 37715225
PMC: 10503144.
DOI: 10.1186/s12920-023-01655-z.
An Update on Tamoxifen and the Chemo-Preventive Potential of Vitamin E in Breast Cancer Management.
Khallouki F, Hajji L, Saber S, Bouddine T, Edderkaoui M, Bourhia M
J Pers Med. 2023; 13(5).
PMID: 37240924
PMC: 10221210.
DOI: 10.3390/jpm13050754.
Identification and validation of endocrine resistance-related and immune-related long non-coding RNA (lncRNA) signatures for predicting endocrinotherapy response and prognosis in breast cancer.
Yang M, Sun Y, Ji H, Zhang Q
Ann Transl Med. 2023; 10(24):1399.
PMID: 36660659
PMC: 9843421.
DOI: 10.21037/atm-22-6158.
Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors.
Semina S, Alejo L, Chopra S, Kansara N, Kastrati I, Sartorius C
Breast Cancer Res. 2022; 24(1):88.
PMID: 36482488
PMC: 9733334.
DOI: 10.1186/s13058-022-01585-1.
Estrogen Receptor Alpha and ESR1 Mutations in Breast Cancer.
Patel J, Jeselsohn R
Adv Exp Med Biol. 2022; 1390:171-194.
PMID: 36107319
DOI: 10.1007/978-3-031-11836-4_10.
Anti-Inflammation and Anti-Pyroptosis Activities of Mangiferin via Suppressing NF-κB/NLRP3/GSDMD Signaling Cascades.
Feng M, Wei S, Zhang S, Yang Y
Int J Mol Sci. 2022; 23(17).
PMID: 36077522
PMC: 9456045.
DOI: 10.3390/ijms231710124.
Macrophages as tools and targets in cancer therapy.
Mantovani A, Allavena P, Marchesi F, Garlanda C
Nat Rev Drug Discov. 2022; 21(11):799-820.
PMID: 35974096
PMC: 9380983.
DOI: 10.1038/s41573-022-00520-5.
Computational approaches to identify a novel binding site of BHPI on estrogen receptor alpha.
Bean M, Alkohaif R, Anbari A, Fedraw C, Ghantasala V, Gojcaj F
Steroids. 2022; 186():109075.
PMID: 35792153
PMC: 11733981.
DOI: 10.1016/j.steroids.2022.109075.
Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells.
Semina S, Pal P, Kansara N, Huggins R, Alarid E, Greene G
Breast Cancer Res. 2022; 24(1):19.
PMID: 35264224
PMC: 8908626.
DOI: 10.1186/s13058-022-01515-1.
An Optimized ChIP-Seq Protocol to Determine Chromatin Binding of Estrogen Receptor Beta.
Indukuri R, Damdimopoulos A, Williams C
Methods Mol Biol. 2022; 2418:203-221.
PMID: 35119668
DOI: 10.1007/978-1-0716-1920-9_13.
The use of resveratrol in the treatment of obstructive sleep apnea and cancer: a commentary on common targets.
Porcacchia A, Moreira G, Andersen M, Tufik S
J Clin Sleep Med. 2022; 18(1):333-334.
PMID: 34984973
PMC: 8807903.
DOI: 10.5664/jcsm.9532.
The Bioinformatics-Based Analysis Identifies 7 Immune-Related Genes as Prognostic Biomarkers for Colon Cancer.
Pan J, Weng Z, Xue C, Lin B, Lin M
Front Oncol. 2021; 11:726701.
PMID: 34900677
PMC: 8663025.
DOI: 10.3389/fonc.2021.726701.
Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment.
Li Y, Kong X, Xuan L, Wang Z, Huang Y
J Cell Mol Med. 2021; 25(22):10327-10348.
PMID: 34651424
PMC: 8581311.
DOI: 10.1111/jcmm.16946.